# C19orf12

## Overview
C19orf12 is a gene located on chromosome 19 that encodes a mitochondrial membrane-associated protein involved in lipid metabolism and cellular stress responses. The protein, known as chromosome 19 open reading frame 12, is characterized by transmembrane glycine zipper motifs, which are crucial for its function and localization within the mitochondria, endoplasmic reticulum, and mitochondria-associated membranes. These motifs facilitate interactions between transmembrane helices, playing a significant role in mitochondrial calcium homeostasis and autophagy regulation. The protein's involvement in these processes underscores its importance in maintaining cellular homeostasis. Mutations in C19orf12 are linked to mitochondrial membrane protein-associated neurodegeneration (MPAN), a subtype of neurodegeneration with brain iron accumulation, and hereditary spastic paraplegia type 43 (SPG43), highlighting its clinical significance in neurodegenerative diseases (Hogarth2013New; Landouré2013Hereditary; Venco2015Mutations).

## Structure
The C19orf12 gene encodes a mitochondrial membrane protein involved in lipid metabolism. The protein is characterized by the presence of transmembrane glycine zipper motifs, which are crucial for its function and are involved in the dimerization of transmembrane helices. These motifs are characterized by patterns like GxxxGxxxG and are common in membrane proteins, facilitating interactions between transmembrane helices (Venco2015Mutations).

The protein structure includes two α-helices in the transmembrane region and a soluble domain that forms a right-handed superhelical structure, similar to bacterial MgtE transporters. The soluble domain is homologous to the N-terminal regulatory domain of bacterial MgtE transporters, which are involved in Mg2+ transport (Venco2015Mutations). The C19orf12 protein is highly conserved across species, with significant sequence identity between humans and zebrafish (Hartig2011Absence; Mignani2020The).

C19orf12 produces two protein isoforms in humans, consisting of 141 and 152 amino acids, respectively. The longer isoform is present in mitochondria, the endoplasmic reticulum, and mitochondria-associated membranes, indicating its significant role in cellular biology (Hartig2011Absence; Mignani2020The).

## Function
The C19orf12 gene encodes a mitochondrial membrane-associated protein that plays a role in lipid metabolism and cellular stress responses. In healthy human cells, the C19orf12 protein is primarily localized in the mitochondria, endoplasmic reticulum (ER), and mitochondria-associated membranes (MAM), which are critical for lipid transfer and calcium ion exchange between these organelles (Venco2015Mutations). The protein contains transmembrane glycine zipper motifs, which are essential for its correct localization and function, particularly in response to oxidative stress (Venco2015Mutations).

C19orf12 is involved in mitochondrial calcium homeostasis and autophagy regulation. Under oxidative stress, the protein changes its localization, forming aggregates near the mitochondrial network, which suggests a role in managing oxidative stress and influencing autophagic processes (Venco2015Mutations). The protein's overexpression has been shown to induce autophagic activity, as evidenced by the conversion of the autophagic marker LC3 and reduction of p62 levels, indicating active autophagic flux (Venco2015Mutations). These functions highlight the importance of C19orf12 in maintaining cellular homeostasis and its potential involvement in neurodegenerative conditions when mutated.

## Clinical Significance
Mutations in the C19orf12 gene are associated with mitochondrial membrane protein-associated neurodegeneration (MPAN), a subtype of neurodegeneration with brain iron accumulation (NBIA). MPAN is characterized by cognitive decline, neuropsychiatric abnormalities, and motor neuronopathy, with iron accumulation particularly in the substantia nigra and globus pallidus (Hogarth2013New). The condition can follow both autosomal recessive and dominant inheritance patterns. Autosomal recessive MPAN is often linked to a common Polish founder deletion, while autosomal dominant cases have been identified with nonsense sequence variations that may cause disease through a dominant negative mechanism (Gregory2019Autosomal).

Clinical features of MPAN include optic atrophy, dysarthria, spasticity, weakness, dystonia, parkinsonism, and cognitive decline, with onset typically between ages 4 and 30 (Hogarth2013New). The presence of Lewy bodies and neurites in various brain regions is noted, with a higher burden of neocortical Lewy pathology compared to typical sporadic Lewy body disease (Hogarth2013New). Mutations in C19orf12 have also been linked to hereditary spastic paraplegia type 43 (SPG43), characterized by progressive spasticity and weakness in the lower limbs (Landouré2013Hereditary).

## Interactions
C19orf12 is a mitochondrial protein involved in various cellular processes, including lipid metabolism and mitochondrial function. The protein contains glycine zipper motifs, which are common in membrane proteins and facilitate interactions between transmembrane helices (Venco2015Mutations). These motifs are crucial for the protein's localization and function, as mutations in these regions can lead to mislocalization and impaired functionality (Venco2015Mutations).

C19orf12 is associated with mitochondrial membranes and is believed to interact with other mitochondrial proteins. It has been suggested that C19orf12 may act as a regulatory protein for human MgtE transporters, with its glycine zipper motifs playing a role in the dimerization of transmembrane helices (Venco2015Mutations). The protein's involvement in lipid metabolism and its presence in mitochondria-associated membranes suggest it may participate in lipid transfer and calcium ion exchange between the endoplasmic reticulum and mitochondria (Venco2015Mutations).

The protein's interactions are also linked to its role in autophagy regulation. Wild-type C19orf12 overexpression induces autophagic marker conversion, indicating a role in autophagy that is dependent on its proper localization (Venco2015Mutations). These interactions highlight the importance of C19orf12 in maintaining cellular homeostasis and its potential involvement in neurodegenerative diseases.


## References


[1. (Gregory2019Autosomal) Allison Gregory, Mitesh Lotia, Suh Young Jeong, Rachel Fox, Dolly Zhen, Lynn Sanford, Jeff Hamada, Amir Jahic, Christian Beetz, Alison Freed, Manju A. Kurian, Thomas Cullup, Marlous C. M. van der Weijden, Vy Nguyen, Naly Setthavongsack, Daphne Garcia, Victoria Krajbich, Thao Pham, Randy Woltjer, Benjamin P. George, Kelly Q. Minks, Alexander R. Paciorkowski, Penelope Hogarth, Joseph Jankovic, and Susan J. Hayflick. Autosomal dominant mitochondrial membrane protein‐associated neurodegeneration (mpan). Molecular Genetics &amp; Genomic Medicine, May 2019. URL: http://dx.doi.org/10.1002/mgg3.736, doi:10.1002/mgg3.736. This article has 39 citations.](https://doi.org/10.1002/mgg3.736)

[2. (Mignani2020The) Luca Mignani, Daniela Zizioli, Giuseppe Borsani, Eugenio Monti, and Dario Finazzi. The downregulation of c19orf12 negatively affects neuronal and musculature development in zebrafish embryos. Frontiers in Cell and Developmental Biology, December 2020. URL: http://dx.doi.org/10.3389/fcell.2020.596069, doi:10.3389/fcell.2020.596069. This article has 11 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fcell.2020.596069)

[3. (Venco2015Mutations) Paola Venco, Massimo Bonora, Carlotta Giorgi, Elena Papaleo, Arcangela Iuso, Holger Prokisch, Paolo Pinton, and Valeria Tiranti. Mutations of c19orf12, coding for a transmembrane glycine zipper containing mitochondrial protein, cause mis-localization of the protein, inability to respond to oxidative stress and increased mitochondrial ca2+. Frontiers in Genetics, May 2015. URL: http://dx.doi.org/10.3389/fgene.2015.00185, doi:10.3389/fgene.2015.00185. This article has 50 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fgene.2015.00185)

[4. (Landouré2013Hereditary) Guida Landouré, Peng-Peng Zhu, Charles M. Lourenço, Janel O. Johnson, Camilo Toro, Katherine V. Bricceno, Carlo Rinaldi, Katherine G. Meilleur, Modibo Sangaré, Oumarou Diallo, Tyler M. Pierson, Hiroyuki Ishiura, Shoji Tsuji, Nichole Hein, John K. Fink, Marion Stoll, Garth Nicholson, Michael A. Gonzalez, Fiorella Speziani, Alexandra Dürr, Giovanni Stevanin, Leslie G. Biesecker, John Accardi, Dennis M. D. Landis, William A. Gahl, Bryan J. Traynor, Wilson Marques, Stephan Züchner, Craig Blackstone, Kenneth H. Fischbeck, and Barrington G. Burnett. Hereditary spastic paraplegia type 43 (spg43) is caused by mutation inc19orf12. Human Mutation, 34(10):1357–1360, August 2013. URL: http://dx.doi.org/10.1002/humu.22378, doi:10.1002/humu.22378. This article has 77 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1002/humu.22378)

[5. (Hartig2011Absence) Monika B. Hartig, Arcangela Iuso, Tobias Haack, Tomasz Kmiec, Elzbieta Jurkiewicz, Katharina Heim, Sigrun Roeber, Victoria Tarabin, Sabrina Dusi, Malgorzata Krajewska-Walasek, Sergiusz Jozwiak, Maja Hempel, Juliane Winkelmann, Matthias Elstner, Konrad Oexle, Thomas Klopstock, Wolfgang Mueller-Felber, Thomas Gasser, Claudia Trenkwalder, Valeria Tiranti, Hans Kretzschmar, Gerd Schmitz, Tim M. Strom, Thomas Meitinger, and Holger Prokisch. Absence of an orphan mitochondrial protein, c19orf12, causes a distinct clinical subtype of neurodegeneration with brain iron accumulation. The American Journal of Human Genetics, 89(4):543–550, October 2011. URL: http://dx.doi.org/10.1016/j.ajhg.2011.09.007, doi:10.1016/j.ajhg.2011.09.007. This article has 207 citations.](https://doi.org/10.1016/j.ajhg.2011.09.007)

[6. (Hogarth2013New) Penelope Hogarth, Allison Gregory, Michael C. Kruer, Lynn Sanford, Wendy Wagoner, Marvin R. Natowicz, Robert T. Egel, S.H. Subramony, Jennifer G. Goldman, Elizabeth Berry-Kravis, Nicola C. Foulds, Simon R. Hammans, Isabelle Desguerre, Diana Rodriguez, Callum Wilson, Andrea Diedrich, Sarah Green, Huong Tran, Lindsay Reese, Randall L. Woltjer, and Susan J. Hayflick. New nbia subtype: genetic, clinical, pathologic, and radiographic features of mpan. Neurology, 80(3):268–275, January 2013. URL: http://dx.doi.org/10.1212/wnl.0b013e31827e07be, doi:10.1212/wnl.0b013e31827e07be. This article has 139 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1212/wnl.0b013e31827e07be)